173 related articles for article (PubMed ID: 38579048)
1. The CXCR4 might be a potential biomarker for esophageal squamous cell carcinoma: A meta-analysis.
Chen P; Zhang YL; Zhang XL; Guo Y; Tang PP
Medicine (Baltimore); 2024 Apr; 103(14):e37681. PubMed ID: 38579048
[TBL] [Abstract][Full Text] [Related]
2. CXCL12 expression promotes esophageal squamous cell carcinoma proliferation and worsens the prognosis.
Uchi Y; Takeuchi H; Matsuda S; Saikawa Y; Kawakubo H; Wada N; Takahashi T; Nakamura R; Fukuda K; Omori T; Kitagawa Y
BMC Cancer; 2016 Jul; 16():514. PubMed ID: 27439769
[TBL] [Abstract][Full Text] [Related]
3. Expression of CXCL12/CXCR4 and its correlation to prognosis in esophageal squamous cell carcinoma.
Wang DF; Lou N; Zeng CG; Zhang X; Chen FJ
Ai Zheng; 2009 Feb; 28(2):154-8. PubMed ID: 19550128
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
[TBL] [Abstract][Full Text] [Related]
5. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.
Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T
Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444
[TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of HIF-1α and esophageal squamous cell carcinoma (ESCC) risk.
Sun G; Hu W; Lu Y; Wang Y
Pathol Oncol Res; 2013 Oct; 19(4):685-93. PubMed ID: 23658132
[TBL] [Abstract][Full Text] [Related]
7. Association between positive murine double minute 2 expression and clinicopathological characteristics of esophageal squamous cell carcinoma: a meta-analysis.
Chen JY; Yang H; Wen J; Luo KJ; Liu QW; Lei JY; Zhen YZ; Fu JH
Dis Esophagus; 2016 Oct; 29(7):856-863. PubMed ID: 25873358
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic significance of CXCR4 expressions in patients with esophageal squamous cell carcinoma.
Yang X; Lu Q; Xu Y; Liu C; Sun Q
Pathol Res Pract; 2020 Jan; 216(1):152787. PubMed ID: 31859114
[TBL] [Abstract][Full Text] [Related]
9. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and prognostic significance of survivin over-expression in patients with esophageal squamous cell carcinoma: a meta-analysis.
Li C; Li Z; Zhu M; Zhao T; Chen L; Ji W; Chen H; Su C
PLoS One; 2012; 7(9):e44764. PubMed ID: 23028610
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
12. Expression of CXCL12 and its receptor CXCR4 correlates with lymph node metastasis in submucosal esophageal cancer.
Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Sakurai T; Owaki T; Aikou T
J Surg Oncol; 2008 Apr; 97(5):433-8. PubMed ID: 18176915
[TBL] [Abstract][Full Text] [Related]
13. [Study on the prognostic influencing factors of esophageal squamous cell carcinoma and the predictive value of inflammatory reaction indexes on its postoperative recurrence].
Wang X; Wang Z; Lu WL; Zhao GF
Zhonghua Zhong Liu Za Zhi; 2023 Feb; 45(2):160-164. PubMed ID: 36781237
[No Abstract] [Full Text] [Related]
14. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
Liu L; Yang Z; Ni W; Xuan Y
Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
[TBL] [Abstract][Full Text] [Related]
15. Slug is a predictor of poor prognosis in esophageal squamous cell carcinoma patients.
Hasan MR; Sharma R; Saraya A; Chattopadhyay TK; DattaGupta S; Walfish PG; Chauhan SS; Ralhan R
PLoS One; 2013; 8(12):e82846. PubMed ID: 24367561
[TBL] [Abstract][Full Text] [Related]
16. Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients.
Tan HZ; Wu ZY; Wu JY; Long L; Jiao JW; Peng YH; Xu YW; Li SS; Wang W; Zhang JJ; Li EM; Xu LY
BMC Cancer; 2016 Jul; 16():560. PubMed ID: 27472962
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic significance of hypoxia-inducible factor-1α in esophageal squamous cell carcinoma: a meta-analysis.
Ping W; Sun W; Zu Y; Chen W; Fu X
Tumour Biol; 2014 May; 35(5):4401-9. PubMed ID: 24425106
[TBL] [Abstract][Full Text] [Related]
18. [Expression level and clinical significance of LncRNA HOXA11-AS in esophageal squamous cell carcinoma patients].
Sun XY; Wang XF; Cui YB; Cao XG; Zhao RH; Wei HY; Cao W; Wu W
Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):186-190. PubMed ID: 29575836
[No Abstract] [Full Text] [Related]
19. Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma.
Huan J; Gao Y; Xu J; Sheng W; Zhu W; Zhang S; Cao J; Ji J; Zhang L; Tian Y
Int J Clin Exp Pathol; 2015; 8(3):3054-61. PubMed ID: 26045817
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated circular RNAs as novel biomarkers in esophageal squamous cell carcinoma: a meta-analysis.
Guo C; Mi J; Li H; Su P; Nie H
Cancer Med; 2021 Nov; 10(22):7895-7908. PubMed ID: 34704390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
